Literature DB >> 26157685

Exome sequencing in a breast cancer family without BRCA mutation.

Jae Myoung Noh1, Jihun Kim2, Dae Yeon Cho2, Doo Ho Choi1, Won Park1, Seung Jae Huh1.   

Abstract

PURPOSE: We performed exome sequencing in a breast cancer family without BRCA mutations.
MATERIALS AND METHODS: A family that three sisters have a history of breast cancer was selected for analysis. There were no family members with breast cancer in the previous generation. Genetic testing for BRCA mutation was negative, even by the multiplex ligation-dependent probe amplification method. Two sisters with breast cancer were selected as affected members, while the mother of the sisters was a non-affected member. Whole exome sequencing was performed on the HiSeq 2000 platform with paired-end reads of 101 bp in the three members.
RESULTS: We identified 19,436, 19,468, and 19,345 single-nucleotide polymorphisms (SNPs) in the coding regions. Among them, 8,759, 8,789, and 8,772 were non-synonymous SNPs, respectively. After filtering out 12,843 synonymous variations and 12,105 known variations with indels found in the dbSNP135 or 1000 Genomes Project database, we selected 73 variations in the samples from the affected sisters that did not occur in the sample from the unaffected mother. Using the Sorting Intolerant From Tolerant (SIFT), PolyPhen-2, and MutationTaster algorithms to predict amino acid substitutions, the XCR1, DLL1, TH, ACCS, SPPL3, CCNF, and SRL genes were risky among all three algorithms, while definite candidate genes could not be conclusively determined.
CONCLUSION: Using exome sequencing, we found 7 variants for a breast cancer family without BRCA mutations. Genetic evidence of disease association should be confirmed by future studies.

Entities:  

Keywords:  BRCA; Breast neoplasms; Exome

Year:  2015        PMID: 26157685      PMCID: PMC4493427          DOI: 10.3857/roj.2015.33.2.149

Source DB:  PubMed          Journal:  Radiat Oncol J        ISSN: 2234-1900


  25 in total

Review 1.  Genetic predisposition to breast cancer: past, present, and future.

Authors:  Clare Turnbull; Nazneen Rahman
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

2.  Can unknown predisposition in familial breast cancer be family-specific?

Authors:  Henry Lynch; Hongxiu Wen; Yeong C Kim; Carrie Snyder; Yulia Kinarsky; Pei Xian Chen; Fengxia Xiao; David Goldgar; Kenneth H Cowan; San Ming Wang
Journal:  Breast J       Date:  2013-06-26       Impact factor: 2.431

3.  PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.

Authors:  Jin Ho Kim; Doo Ho Choi; Dae Yeon Cho; Sei Hyun Ahn; Byung Ho Son; Bruce G Haffty
Journal:  Breast Cancer Res Treat       Date:  2010-03-06       Impact factor: 4.872

4.  Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004.

Authors:  Sei Hyun Ahn; Keun Young Yoo
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.

Authors:  Vincenzo D'Angiolella; Valerio Donato; Sangeetha Vijayakumar; Anita Saraf; Laurence Florens; Michael P Washburn; Brian Dynlacht; Michele Pagano
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

7.  The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.

Authors:  Doo Ho Choi; Dae Yeon Cho; Min Hyuk Lee; Hee Sook Park; Sei Hyun Ahn; Byung Ho Son; Bruce G Haffty
Journal:  Breast Cancer Res Treat       Date:  2008-01-03       Impact factor: 4.872

8.  The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.

Authors:  Sang-Ah Han; Sung-Won Kim; Eunyoung Kang; Sue K Park; Sei-Hyun Ahn; Min Hyuk Lee; Seok-Jin Nam; Wonshik Han; Young Tae Bae; Hyun-Ah Kim; Young Up Cho; Myung Chul Chang; Nam Sun Paik; Ki-Tae Hwang; Sei Joong Kim; Dong-Young Noh; Doo Ho Choi; Woo-Chul Noh; Lee Su Kim; Ku Sang Kim; Young Jin Suh; Jeong Eon Lee; Yongsik Jung; Byung-In Moon; Jung-Hyun Yang; Byung Ho Son; Cha Kyong Yom; Sung Yong Kim; Hyde Lee; Sung Hoo Jung
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

9.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  8 in total

Review 1.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

2.  Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.

Authors:  Eunjin Jwa; Kyung Hwan Shin; Ja Young Kim; Young Hee Park; So-Youn Jung; Eun Sook Lee; In Hae Park; Keun Seok Lee; Jungsil Ro; Yeon-Joo Kim; Tae Hyun Kim
Journal:  Cancer Res Treat       Date:  2016-02-18       Impact factor: 4.679

3.  Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.

Authors:  Yosr Hamdi; Maroua Boujemaa; Mariem Ben Rekaya; Cherif Ben Hamda; Najah Mighri; Houda El Benna; Nesrine Mejri; Soumaya Labidi; Nouha Daoud; Chokri Naouali; Olfa Messaoud; Mariem Chargui; Kais Ghedira; Mohamed Samir Boubaker; Ridha Mrad; Hamouda Boussen; Sonia Abdelhak
Journal:  J Transl Med       Date:  2018-06-07       Impact factor: 5.531

4.  Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients.

Authors:  Duna H Barakeh; Rasha Aljelaify; Yara Bashawri; Amal Almutairi; Fatimah Alqubaishi; Mohammed Alnamnakani; Latifa Almubarak; Abdulrahman Al Naeem; Fatema Almushawah; May Alrashed; Malak Abedalthagafi
Journal:  Oncotarget       Date:  2021-03-30

5.  Methylation of Immune-Related Genes in Peripheral Blood Leukocytes and Breast Cancer.

Authors:  Tian Tian; JinMing Fu; DaPeng Li; YuPeng Liu; HongRu Sun; Xuan Wang; XianYu Zhang; Ding Zhang; Ting Zheng; Yashuang Zhao; Da Pang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

6.  Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer.

Authors:  Nian-Qiu Liu; Wei-Han Cao; Xing Wang; Junyao Chen; Jianyun Nie
Journal:  Oncol Lett       Date:  2022-09-05       Impact factor: 3.111

7.  Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.

Authors:  Giovana T Torrezan; Fernanda G Dos Santos R de Almeida; Márcia C P Figueiredo; Bruna D de Figueiredo Barros; Cláudia A A de Paula; Renan Valieris; Jorge E S de Souza; Rodrigo F Ramalho; Felipe C C da Silva; Elisa N Ferreira; Amanda F de Nóbrega; Paula S Felicio; Maria I Achatz; Sandro J de Souza; Edenir I Palmero; Dirce M Carraro
Journal:  Front Genet       Date:  2018-05-07       Impact factor: 4.599

Review 8.  Novel applications of next-generation sequencing in breast cancer research.

Authors:  Rong Ma; Jianping Gong; Xiaowei Jiang
Journal:  Genes Dis       Date:  2017-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.